Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide

AIMS: To compare adherence (proportion of days covered [PDC]), persistence, and treatment patterns among patients with type 2 diabetes mellitus (T2DM) newly initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs). More specifically, the main objectives were to compare dulaglutide vs exenatid...

Descripción completa

Detalles Bibliográficos
Autores principales: Alatorre, Carlos, Fernández Landó, Laura, Yu, Maria, Brown, Katelyn, Montejano, Leslie, Juneau, Paul, Mody, Reema, Swindle, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485056/
https://www.ncbi.nlm.nih.gov/pubmed/28181725
http://dx.doi.org/10.1111/dom.12902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485056/
https://www.ncbi.nlm.nih.gov/pubmed/28181725
http://dx.doi.org/10.1111/dom.12902

Ejemplares similares